Trilogy Capital’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Trilogy Capital’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.23M	Sell	26,645 -190,256	-88%	-$28.3M	0.16%	100
2026 Q1	$31.8M	Buy	216,901 +42,773	+25%	+$6.6M	1.4%	20
2025 Q4	$27M	Buy	174,128 +53,384	+44%	+$8M	1.2%	21
2025 Q3	$16.8M	Sell	120,744 -88,609	-42%	-$12M	0.78%	29
2025 Q2	$28.2M	Buy	209,353 +202,085	+2,780%	+$27.3M	1.37%	20
2025 Q1	$1.06M	Sell	7,268 -583	-7%	-$84.7K	0.06%	167
2024 Q4	$1.08M	Sell	7,851 -51,894	-87%	-$7.59M	0.06%	172
2024 Q3	$9.2M	Sell	59,745 -9,568	-14%	-$1.45M	0.46%	50
2024 Q2	$10.1M	Buy	69,313 +9,758	+16%	+$1.4M	0.55%	52
2024 Q1	$8.8M	Buy	59,555 +34,597	+139%	+$4.96M	0.51%	51
2023 Q4	$3.4M	Sell	24,958 -132,635	-84%	-$17.3M	0.21%	73
2023 Q3	$20.3M	Buy	157,593 +53,465	+51%	+$7.1M	1.37%	22
2023 Q2	$14.2M	Buy	104,128 +98,495	+1,749%	+$13M	0.9%	38
2023 Q1	$729K	Sell	5,633 -118,473	-95%	-$15.5M	0.05%	139
2022 Q4	$16.9M	Buy	124,106 +121,136	+4,079%	+$16.1M	1.2%	26
2022 Q3	$360K	Buy	2,970 +1,409	+90%	+$181K	0.03%	138
2022 Q2	$200K	Buy	+1,561	New	+$205K	0.02%	155
2018 Q3	–	Sell	-6	Closed	-$1K	–	660
2018 Q2	$1K	Hold	6	–	–	﹤0.01%	558
2018 Q1	$0	Buy	+6	New	+$511	﹤0.01%	511

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Trilogy Capital's XLV Position: Q2 2026 in Review

Trilogy Capital reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 88% in Q2 2026, selling an estimated $28.3M and leaving 26,645 shares worth $4.23M. The position accounts for 0.16% of the portfolio, ranked #100.

Trilogy Capital first reported a position in XLV in Q1 2018 and has held it in 19 quarters since. The position peaked at $31.8M in Q1 2026. 1,852 funds tracked by Wall St. Rank hold XLV as of Q2 2026.

Trilogy Capital held 26,645 shares of State Street Health Care Select Sector SPDR ETF worth $4.23M as of Q2 2026.
Trilogy Capital sold 190,256 State Street Health Care Select Sector SPDR ETF shares in Q2 2026, an estimated $28.3M.
State Street Health Care Select Sector SPDR ETF made up 0.16% of Trilogy Capital's portfolio in Q2 2026, its #100 holding.
Trilogy Capital first reported a position in State Street Health Care Select Sector SPDR ETF in Q1 2018 and has held it in 19 quarters since.
Trilogy Capital's State Street Health Care Select Sector SPDR ETF position peaked at $31.8M in Q1 2026.
1,852 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.